Companies / Atyr Pharma Inc
Atyr Pharma Inc
Financials · FY2025
Ownership
98.1M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 1.02% | 1,003,116 |
| 10%+ / strategic | 6.05% | 5,935,900 |
| Institutions | 36.23% | 35,534,556 |
| Public float | 56.70% | 55,613,853 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Schimmel PaulDirector | 0.79% | 779,143 |
Shukla SanjayCEOPresident and CEO · Director | 0.16% | 153,553 |
Broadfoot Jill MarieChief Financial Officer | 0.04% | 37,296 |
Denyes NancyGeneral Counsel | 0.03% | 33,124 |
Benevich EricDirector | — | — |
Coughlin TimothyDirector | — | — |
Gross Jane ADirector | — | — |
Lucas SvetlanaDirector | — | — |
Zaknoen SaraDirector | — | — |
Institutional holders 89
View all →| Holder | Value | % of shares |
|---|---|---|
| $13.60M | 1.06% | |
| $11.51M | 14.98% | |
| $8.20M | 10.71% | |
| $3.89M | 5.06% | |
| $1.86M | 2.43% | |
| $1.28M | 1.67% | |
| $1.27M | 1.66% | |
| $1.10M | 1.43% | |
| $1.09M | 1.86% | |
| $892.8K | 1.17% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | Schimmel Paul Director | Buy | Common Stock | $49.6K | +100K +14.72% | 779,143 0.79% of shares | low |
| Feb 4, 2026 | Shukla Sanjay CEO | Sell | Common Stock | $3.7K | -4K -2.38% | 153,553 0.16% of shares | low |
| Feb 4, 2026 | Broadfoot Jill Marie Executive | Sell | Common Stock | $1.5K | -2K -4.01% | 37,296 0.04% of shares | low |
| Feb 4, 2026 | Denyes Nancy Executive | Sell | Common Stock | $1.1K | -1K -3.26% | 33,124 0.03% of shares | low |
| May 11, 2026 | Lucas Svetlana Director | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.05% of shares | low |
| May 11, 2026 | Gross Jane A Director | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.05% of shares | low |
| May 11, 2026 | Benevich Eric Director | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.05% of shares | low |
| May 11, 2026 | Zaknoen Sara Director | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.05% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ATYR | — | 002120202 |